Doxorubicin hcl injection
Products billed under this code include Adriamycin, Doxorubicin HCl.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J9000
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Adriamycin | Hikma Pharmaceuticals USA Inc. | 00143-9277-01 | 5 | $15.60 |
| Doxorubicin HCl | Pfizer Inc | 00069-0255-10 | 2 | $6.24 |
| Doxorubicin HCl | Pfizer Inc | 00069-0277-02 | 2 | $6.24 |
| Doxorubicin HCl | Pfizer Inc | 00069-0343-02 | 5 | $15.60 |
| Doxorubicin HCl | Pfizer Inc | 00069-0358-20 | 1 | $3.12 |
| Doxorubicin HCl | Pfizer Inc | 00069-1442-04 | 20 | $62.40 |
| Doxorubicin HCl | Pfizer Inc | 00069-1542-20 | 20 | $62.40 |
| Doxorubicin HCl | Pfizer Inc | 00069-3030-20 | 1 | $3.12 |
| Doxorubicin HCl | Pfizer Inc | 00069-3031-20 | 2 | $6.24 |
| Doxorubicin HCl | Pfizer Inc | 00069-3032-20 | 5 | $15.60 |
Show all 42 products
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Doxorubicin HCl | Pfizer Inc | 00069-3034-20 | 20 | $62.40 |
| Doxorubicin HCl | Pfizer Inc | 00069-3358-25 | 5 | $15.60 |
| Doxorubicin HCl | Pfizer Inc | 00069-4004-05 | 1 | $3.12 |
| Doxorubicin HCl | Pfizer Inc | 00069-4015-10 | 2 | $6.24 |
| Doxorubicin HCl | Pfizer Inc | 00069-4026-25 | 5 | $15.60 |
| Doxorubicin HCl | Pfizer Inc | 00069-4031-12 | 2 | $6.24 |
| Doxorubicin HCl | Pfizer Inc | 00069-4037-01 | 20 | $62.40 |
| Doxorubicin HCl | Pfizer Inc | 00069-4205-05 | 1 | $3.12 |
| Doxorubicin HCl | Pfizer Inc | 00069-5629-05 | 1 | $3.12 |
| Doxorubicin HCl | Hikma Pharmaceuticals USA Inc. | 00143-9084-01 | 1 | $3.12 |
| Doxorubicin HCl | Hikma Pharmaceuticals USA Inc. | 00143-9085-01 | 2 | $6.24 |
| Doxorubicin HCl | Hikma Pharmaceuticals USA Inc. | 00143-9086-01 | 5 | $15.60 |
| Doxorubicin HCl | Hikma Pharmaceuticals USA Inc. | 00143-9087-01 | 20 | $62.40 |
| Doxorubicin HCl | Hikma Pharmaceuticals USA Inc. | 00143-9088-01 | 1 | $3.12 |
| Doxorubicin HCl | Hikma Pharmaceuticals USA Inc. | 00143-9089-01 | 2 | $6.24 |
| Doxorubicin HCl | Hikma Pharmaceuticals USA Inc. | 00143-9090-01 | 5 | $15.60 |
| Doxorubicin HCl | Hikma Pharmaceuticals USA Inc. | 00143-9091-01 | 20 | $62.40 |
| Doxorubicin HCl | Hikma Pharmaceuticals USA Inc. | 00143-9092-01 | 1 | $3.12 |
| Doxorubicin HCl | Hikma Pharmaceuticals USA Inc. | 00143-9093-01 | 5 | $15.60 |
| Doxorubicin HCl | Sagent Pharmaceuticals | 25021-0207-05 | 10 | $31.20 |
| Doxorubicin HCl | Sagent Pharmaceuticals | 25021-0207-25 | 5 | $15.60 |
| Doxorubicin HCl | Sagent Pharmaceuticals | 25021-0207-51 | 20 | $62.40 |
| Doxorubicin HCl | Actavis Pharma, Inc. | 45963-0733-55 | 1 | $3.12 |
| Doxorubicin HCl | Actavis Pharma, Inc. | 45963-0733-57 | 2 | $6.24 |
| Doxorubicin HCl | Actavis Pharma, Inc. | 45963-0733-60 | 20 | $62.40 |
| Doxorubicin HCl | Actavis Pharma, Inc. | 45963-0733-68 | 5 | $15.60 |
| Doxorubicin HCl | FreseniUS Kabi USA, LLC | 63323-0101-61 | 20 | $62.40 |
| Doxorubicin HCl | FreseniUS Kabi USA, LLC | 63323-0883-05 | 1 | $3.12 |
| Doxorubicin HCl | FreseniUS Kabi USA, LLC | 63323-0883-30 | 5 | $15.60 |
| Doxorubicin HCl | Mylan Institutional LLC | 67457-0436-50 | 5 | $15.60 |
| Doxorubicin HCl | Athenex Pharmaceutical Division, LLC | 70860-0208-25 | 5 | $15.60 |
| Doxorubicin HCl | Athenex Pharmaceutical Division, LLC | 70860-0208-51 | 20 | $62.40 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $3.12 | +$0.41 | 10 MG | Doxorubicin hcl injection | v1, posted September 17, 2026 |
| 3Q26 | $2.71 | −$0.019 | 10 MG | Doxorubicin hcl injection | v1, posted September 15, 2026 |
| 2Q26 | $2.729 | −$0.054 | 10 MG | Doxorubicin hcl injection | v1, posted September 15, 2026 |
| 1Q26 | $2.783 | −$0.235 | 10 MG | Doxorubicin hcl injection | v1, posted September 15, 2026 |
| 4Q25 | $3.018 | +$0.295 | 10 MG | Doxorubicin hcl injection | v1, posted September 8, 2026 |
| 3Q25 | $2.723 | −$0.43 | 10 MG | Doxorubicin hcl injection | v1, posted March 10, 2026 |
| 2Q25 | $3.153 | −$0.167 | 10 MG | Doxorubicin hcl injection | v1, posted March 10, 2026 |
| 1Q25 | $3.32 | +$0.018 | 10 MG | Doxorubicin hcl injection | v1, posted December 19, 2025 |
| 4Q24 | $3.302 | +$0.04 | 10 MG | Doxorubicin hcl injection | v1, posted June 11, 2025 |
| 3Q24 | $3.262 | −$0.384 | 10 MG | Doxorubicin hcl injection | v1, posted June 11, 2025 |
| 2Q24 | $3.646 | +$0.367 | 10 MG | Doxorubicin hcl injection | v1, posted March 11, 2025 |
| 1Q24 | $3.279 | +$0.595 | 10 MG | Doxorubicin hcl injection | v1, posted December 19, 2024 |
| 4Q23 | $2.684 | +$0.183 | 10 MG | Doxorubicin hcl injection | v1, posted October 10, 2024 |
| 3Q23 | $2.501 | +$0.04 | 10 MG | Doxorubicin hcl injection | v1, posted June 5, 2024 |
| 2Q23 | $2.461 | +$0.064 | 10 MG | Doxorubicin hcl injection | v1, posted February 23, 2024 |
| 1Q23 | $2.397 | −$0.03 | 10 MG | Doxorubicin hcl injection | v1, posted December 6, 2023 |
| 4Q22 | $2.427 | −$0.084 | 10 MG | Doxorubicin hcl injection | v1, posted June 22, 2023 |
| 3Q22 | $2.511 | −$0.497 | 10 MG | Doxorubicin hcl injection | v1, posted June 9, 2023 |
| 2Q22 | $3.008 | −$0.476 | 10 MG | Doxorubicin hcl injection | v1, posted December 14, 2022 |
| 1Q22 | $3.484 | +$1.316 | 10 MG | Doxorubicin hcl injection | v1, posted June 8, 2022 |
| 4Q21 | $2.168 | −$0.398 | 10 MG | Doxorubicin hcl injection | v1, posted June 2, 2022 |
| 3Q21 | $2.566 | −$0.089 | 10 MG | Doxorubicin hcl injection | v1, posted June 2, 2022 |
| 2Q21 | $2.655 | +$0.155 | 10 MG | Doxorubicin hcl injection | v1, posted March 1, 2022 |
| 1Q21 | $2.50 | – | 10 MG | Doxorubicin hcl injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024
- 3Q23: 2024-06-05_july-2023-asp-pricing-file.zipposted June 5, 2024
- 2Q23: 2024-02-23_april-2023-asp-pricing-file.zipposted February 23, 2024
- 1Q23: 2023-12-06_january-2023-asp-pricing-file.zipposted December 6, 2023
- 4Q22: 2023-06-22_october-2022-asp-pricing-file.zipposted June 22, 2023
- 3Q22: 2023-06-09_july-2022-asp-pricing-file.zipposted June 9, 2023
- 2Q22: 2022-12-14_april-2022-asp-pricing-file.zipposted December 14, 2022
- 1Q22: 2022-06-08_january-2022-asp-pricing-file.zipposted June 8, 2022
- 4Q21: 2022-06-02_october-2021-asp-pricing-file.zipposted June 2, 2022
- 3Q21: 2022-06-02_july-2021-asp-pricing-file.zipposted June 2, 2022
- 2Q21: 2022-03-01_april-2021-asp-pricing-file.zipposted March 1, 2022
- 1Q21: 2021-12-10_january-2021-asp-pricing-file.zipposted December 10, 2021